-
Optimizing hiPSC-Derived Platelet Production
2026-08-28
A 2026 study establishes an optimized differentiation scheme that increases megakaryocyte and platelet output from human induced pluripotent stem cells while shortening production time and reducing medium-related costs. Its combination of embryoid body scaling, human platelet lysate, and small-molecule control provides a practical framework for generating functional platelets in vitro.
-
(+)-Bicuculline: Practical GABAA Workflow
2026-08-27
This guide explains how to use (+)-Bicuculline as a GABAA receptor antagonist for controlled studies of inhibitory neurotransmission, neuronal signaling, and synaptic NMDA receptor signaling modulation. It is intended for scientific research workflows only and should not be used for diagnostic, clinical, or therapeutic applications.
-
Bradykinin B2 Receptors and Ileal Peristalsis
2026-08-27
Chan and Rudd showed that bradykinin suppresses the peristaltic reflex in guinea pig isolated ileum through bradykinin B2 receptors rather than B1 receptors. Their pressure-threshold assay, combined with selective agonists and antagonists, provides a pharmacological framework for interpreting peptide regulation of intestinal propulsion and for separating receptor-specific effects from nonspecific smooth-muscle actions.
-
Bestatin Hydrochloride: Mechanism-First Guide
2026-08-26
Bestatin hydrochloride, or Ubenimex, is more than a broad aminopeptidase probe. This mechanism-first guide explains how to interpret substrate processing, neuronal signaling, angiogenesis inhibition, and cancer research data without confusing pathway effects with direct target evidence.
-
HyperScribe T7 High Yield RNA Synthesis Kit Plus
2026-08-26
Generate high-yield RNA for mRNA rescue, antisense studies, RNAi, and labeled probe workflows with a scalable T7 transcription system. The kit combines pre-supplemented polymerase, RNase inhibitor, pyrophosphatase, and modified-nucleotide compatibility to simplify demanding in vitro RNA production.
-
IWP-L6: A Strategic Probe of Wnt Metabolism
2026-08-25
IWP-L6 offers translational researchers a potent way to interrogate Wnt biology at the Porcn-dependent ligand maturation step. This thought-leadership analysis connects mechanistic pathway blockade with developmental assays, metabolic osteogenesis, experimental design, and the practical limits that shape cross-species interpretation.
-
ACE2 Peptidase Activity and Angiotensin (1-7)
2026-08-25
The 2024 reference study systematically tested how angiotensin peptide length and terminal residues affect competition for ACE2 activity. Its results identify Angiotensin II and Angiotensin III as the strongest natural substrates in the assay while showing that Angiotensin (1-7), the ACE2-generated product, behaves differently from its precursor.
-
Muscle-Derived BDNF in Early NMJ Assembly
2026-08-24
The reference study shows that muscle-generated BDNF is not merely a diffusible trophic factor: its trafficking, capture, proteolytic maturation, and localized release at podosome-like structures help initiate postsynaptic acetylcholine receptor assembly. By combining live-cell imaging, molecular perturbation, and skeletal muscle-specific knockout models, the work connects subcellular BDNF organization with early neuromuscular junction development.
-
Linoleic Acid (C18:2): Practical Assay Guide
2026-08-24
Linoleic Acid (C18:2(9Z,12Z), SKU C3108) provides a controlled lipid input for oxidative stress, membrane, epithelial migration, erythrocyte, and essential fatty acid deficiency studies. It is appropriate for freshly prepared organic-solvent workflows but should not be selected for aqueous-only assays or experiments requiring long-term solution storage.
-
LAMP1 Switches CXCL10-CXCR3 Macrophage Polarization
2026-08-23
The 2024 International Immunopharmacology study identifies LAMP1 as a context-dependent regulator of CXCL10-CXCR3 signaling in macrophage polarization. Its combination of macrophage perturbation, LAMP1 knockdown, autophagy profiling, and a poly(I:C)-induced lung injury model shows why CXCR3 antagonism can produce different outcomes in inflammatory and non-inflammatory states.
-
Angiotensin II Workflows for Vascular Research
2026-08-22
Build reproducible cell and animal models of receptor-driven inflammation, oxidative stress, hypertension, and vascular remodeling with Angiotensin II. This guide connects practical dosing and storage decisions to macrophage polarization assays, smooth-muscle phenotyping, and abdominal aortic aneurysm research.
-
Sodium Nitroprusside in Sex-Specific Vascular Research
2026-08-22
Sodium Nitroprusside provides a controlled nitric oxide donor challenge for separating vascular smooth muscle responsiveness from angiotensin II, hormonal, and autonomic effects. This workflow connects conscious-mouse telemetry with ex vivo vessel and platelet assays to improve sex-stratified hypertension research.
-
WSP-5 for Reliable H2S Live-Cell Imaging
2026-08-21
Learn how WSP-5 (SKU C3378) can strengthen live-cell imaging of hydrogen sulfide alongside viability, proliferation, and cytotoxicity assays. This scenario-based guide covers probe chemistry, cardiomyocyte compatibility, practical handling, data interpretation, and vendor-selection criteria.
-
Carbapenemase Gene Transfer in CREC
2026-08-20
A 2025 BMC Microbiology study combined plasmid elimination, PCR, antimicrobial susceptibility testing, conjugation, mobile-element analysis, and ERIC-PCR to characterize carbapenem-resistant Enterobacter cloacae from eight Guangdong teaching hospitals. The study found frequent blaNDM-1 carriage and a high observed transfer rate of carbapenemase-encoding genes, emphasizing the value of tracking both resistance phenotypes and genetic mobility in antimicrobial resistance research.
-
CD28–ARS2–PKM Splicing in CD8+ T Cells
2026-08-20
The reference study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing in activated CD8+ T cells, favoring PKM2 over PKM1 and enabling flexible glucose catabolism. Its findings connect nuclear RNA processing with interferon-γ production and antitumor immunity, while showing that this metabolic program is distinct from canonical CD28–PI3K signaling.